CD4+ T cells contribute to antitumor immunity through diverse mechanisms, in which they are required not only for the maintenance of CD8+ CTLs but also for the infiltration of CD8+ CTLs at the tumor site [3]. The gene discussed is CD8A; the disease is neoplasm.